1382EGP
- Active ingredient
- fondaparinux sodium
- Strength
- 2.5mg/0.5ml
- Form
- syringe
- Manufacturer
- glaxo smithkline > phoenix-egypt
- Route
- injection
Uses
Used for prophylaxis of deep vein thrombosis after certain surgeries and for treatment of deep vein thrombosis or pulmonary embolism.
Do not use if
Active major bleeding, severe renal impairment, bacterial endocarditis, thrombocytopenia associated with fondaparinux, or hypersensitivity.
Side effects
Bleeding, anemia, thrombocytopenia, and injection-site reactions may occur.
Warnings
Risk of serious bleeding and spinal or epidural hematomas in patients undergoing spinal procedures.
How it works
Selective Factor Xa inhibitor that potentiates antithrombin III activity and interrupts coagulation.
Storage
Store according to labeled conditions at controlled room temperature.
